Abordagem da Dor em Dermatologia (Parte II)

Bruno Duarte, André Roberto, Salomé Cruz, Joana Cabete

Resumo


A dor é um sintoma universal em Medicina; e na Dermatovenereologia é transversal ao seu domínio médico e cirúrgico. No domínio cirúrgico da especialidade temos a dor aguda peri-operatória, provavelmente mais frequente do que o esperado e cujo tratamento insuficiente implica morbilidade aguda e até potencialmente a longo prazo, dado o risco de cronificação. A dor crónica está associada a várias doenças cutâneas e é muitas vezes causa major de sofrimento para os doentes, dada a sua abordagem ser complexa, desafiante e por vezes infrutífera, agravada pela pouca evidência sobre como tratar apropriadamente o doente dermatológico com dor crónica. Este artigo é a segunda e última parte de uma revisão cujo objetivo é discutir os princípios gerais do tratamento da dor aguda peri- -operatória e crónica no contexto da especialidade. Neste segundo capítulo será abordada a dor relacionada com procedimentos terapêuticos específicos. Por último, será discutida a dor crónica associada a entidades dermatológicas com quadros álgicos significativos.


Palavras-chave


Dermatologia; Doenças da Pele; Dor; Medição da Dor; Procedimentos Cirúrgicos Dermatológicos; Tratamento da Dor

Texto Completo:

PDF

Referências


Briggs M, Nelson EA, Martyn-St James M. Topical agents

or dressings for pain in venous leg ulcers. Cochrane Database

Syst Rev. 2012; 11 :CD001177.

Benedetto AV. A novel use of topical anesthetics to alleviate

the pain of cryotherapy. Skinmed. 2003; 2:307-8.

Gupta AK, Koren G, Shear NH. A double-blind, randomized,

placebo- controlled trial of eutectic lidocaine /

prilocaine cream 5% ( EMLA )@ for analgesia prior to

cryotherapy of warts in children and adults. Pediatr Dermatol.

; 15:129-33.

Mishra S. Safe and less painful injection of triamcenolone

acetonide into a keloid e A technique. Br J Plast Surg.

; 63:e205.

Ono N. Pain-free intralesional injection of triamcinolone

for the treatment of keloid. Scand J Plast Reconstr Hand

Surg. 1999; 33:89-91.

Azad A, Sacks L. Painless steroid injections for hypertrophic

scars and keloids. Br J Plast Surg. 2003; 56:534.

Park KY, Lee Y, Hong JY, Chung WS. Vibration anesthesia

for pain reduction during intralesional steroid injection for

keloid treatment. Dermatol Surg. 2017; 43:724-7.

Ericson MB, Wennberg A. Review of photodynamic therapy

in actinic keratosis and basal cell carcinoma. Ther Clin

Risk Manag. 2008; 4:1-9.

Wan MT, Lin JY. Current evidence and applications of photodynamic

therapy in dermatology. Clin Cosmet Investig

Dermatol. 2014; 7:145-63.

Karrer S, Kohl E, Feise K, Hiepe-Wegener D, Lischner S,

Philipp-Dormston W, et al. Photodynamic therapy for skin

rejuvenation: review and summary of the literature – results

of a consensus conference of an expert group for

aesthetic photodynamic therapy. J Dtsch Dermatol Ges.

:137-48.

Uebelhoer NS, Dover JS. Photodynamic therapy for cosmetic

applications. Dermatol Ther. 2005; 18:242-52.

Virgili A, Osti F, Maranini C, Corazza M. Photodynamic

therapy: parameters predictive of pain. Br J Dermatol.

; 162:460-1.

Waters A, Ibbotson S. Parameters associated with severe

pain during photodynamic therapy: results of a large Scottish

series. Br J Dermatol. 2011; 165:696-8.

Wang B, Shi L, Zhang YF, Zhou Q, Zheng J, Szeimies RM.

Gain with no pain? Pain management in dermatological

photodynamic therapy. Br J Dermatol. 2017; 177:656-

Arits A, van de Weert MM, Nelemans PJ, Kelleners-Smeets

NW. Pain during topical photodynamic therapy: uncomfortable

and unpredictable. J Eur Acad Dermatol Venereol.

; 12:1452-7.

Lindeburg KE, Brogaard HM, Jemec GB. Pain and photodynamic

therapy. Dermatology. 2007; 215:206-8.

Ang JM, Riaz IB, Kamal MU, Paragh G, Zeitouni NC. Photodynamic

therapy and pain: a systematic review. Photodiagnosis

Photodyn Ther. 2017; 19:308-44.

Berking C, Herzinger T, Flaig M, Brenner M, Borelli C,

Degitz K. The efficacy of photodynamic therapy in actinic

cheilitis of the lower lip: a prospective study of 15 patients.

Dermatol Surg. 2007; 33:825-30.

Manuscript A. Pain associated with aminolevulnic acid-

-photodynamic therapy of skin disease. J Am Acad Dermatol.

; 61:1033-3.

Greveling K, Prends E., Liu L, Van Doorn M. Non-invasive

anaesthetic methods for dermatological laser procedures

- a systematic review. J Eur Acad Dermatol Venereol.

;31:1096-110

Campos S. Manual de Anestesiologia Clínica.Lisboa:

Lidel; 2014.

Davis UC. Dermatology Online Journal UC Davis. Dermatol

Online J. 2013; 19:11.

Horvath B, Janse IC, Sibbald GR. Pain management in patients

with hidradenitis suppurativa. J Am Acad Dermatol.

; 73:47-51.

Ryder SA, Stannard CF. Treatment of chronic pain: antidepressant,

antiepileptic and antiarrhythmic drugs. Contin

Educ Anaesth Crit Care Pain. 2005; 5: 18-21.

Basra MK, Shahrukh M. Burden of skin diseases. Expert

Rev Pharmacoecon Outcomes Res. 2009; 9:271-83.

Von Der Werth J, Jemec G. Morbidity in patients with hidradenitis

suppurativa. Br J Dermatol. 2001; 144:809-

Miner A. Concern regarding the safety of tumor necrosis

factor-alfa antagonists in pregnancy. J Am Acad Dermatol.

; 62:706-9.

Gupta R. Post-herpetic neuralgia. Br J Anaesth. 2012;

:81-5.

Werner RN, Nikkels AF, Marinović B, Schäfer M, Czarnecka-

Operacz M, Agius AM, et al. European consensus-based

(S2k) Guideline on the Management of Herpes Zoster

- guided by the European Dermatology Forum (EDF) in

cooperation with the European Academy of Dermatology

and Venereology (EADV), Part 2: Treatment J Eur Acad

Dermatol Venereol. 2016; 31:20-9.

Gauthier A, Breuer J, Carrington D, Martin M, Remy V.

Epidemiology and cost of herpes zoster and post-herpetic

neuralgia in the United Kingdom. Epidemiol Infect. 2009;

:38-47.

Johnson RW, Rice AS. Clinical practice. Postherpetic neuralgia.

N Engl J Med. 2014;371: 1526-33.

Forbes HJ, Thomas SL, Smeeth L, Clayton T, Farmer R,

Bhaskaran K. A systematic review and meta-analysis

of risk factors for postherpetic neuralgia. Pain. 2016;

:30-54.

Sacks GM. Unmet need in the treatment of postherpetic

neuralgia. Am J Manag Care. 2013;19:3-10.

Haanpää M, Cruccu G, Nurmikko TJ, McBride WT, Docu

Axelarad A, et al. Capsaicin 8% patch versus oral pregabalin

in patients with peripheral neuropathic pain. Eur J

Pain. 2016; 20:316-28.

GERMI, Sociedade Portuguesa de Medicina Interna. Vacinação

da população idosa em Portugal: Recomendações

Europeias. [consultado jun 2017] Disponível em: http://

www.spmi.pt/wp-content/uploads/GERMI_37.pdf

Han Y, Zhang J, Chen N, He L, Zhou M, Zhu C. Corticosteroids

for preventing postherpetic neuralgia Cochrane

Database Syst Rev. 2013;3:CD005582.

Parra S, Lacouture P, Giles H. Chronic leg ulcer pain – a

need for effective topical analgesia. J Pain. 2015; 17:S13-

S14.

Green J, Jester R, Mckinley R, Pooler A, Care S. The impact

of chronic venous leg ulcers: a systematic review. J Wound

Care. 2013; 23:601-12.

Gonza RV. Quality of life in people with venous leg ulcers:

an integrative review. J Adv Nurs. 2011; 67:926-44.

Beiteke U, Bigge S, Reichenberger C, Gralow I. Pain and

pain management in dermatology. J Ger Soc Dermatol.2015:967-87.

Bastami S, Frödin T, Ahlner J, Uppugunduri S. Topical

morphine gel in the treatment of painful leg ulcers , a double-

blind , placebo-controlled clinical trial: a pilot study.

Int Wound J. 2012; 9:419-27.

Renner R, Seikowski K, Simon JC. Association of pain

level, health and wound status in patients with chronic leg

ulcers. Acta Derm Venereol. 2014; 94:50-3.

Kahle B, Hermanns H, Gallenkemper G. Evidence-based

treatment of chronic leg ulcers. Dtsch Arztebl Int. 2011;

:231-8.

Bigliardi-qi M, Sumanovski LT, Büchner S, Rufli T, Bigliardi

PL. Mu-opiate receptor and beta-endorphin expression in

nerve endings and keratinocytes in human skin. Dermatology.

; 209:183-9.

Vernassiere C, Cornet C, Trechot P, Alla F, Truchetet F, Cuny

JF, et al. Study to determine the efficacy of topical morphine

on painful chronic skin ulcers. J Wound Care. 2005;1

: 289-93.

Jansen MM, van der Horst JC, van der Valk PG, Kuks PF,

Zylicz Z, van Sorge AA. Pain-relieving properties of topically

applied morphine on arterial leg ulcers: a pilot study.

J Wound Care. 2004; 18:306-11.

Marcio L, Martin M, Barbosa LR. Hyperbaric oxygen therapy

as an adjuvant treatment for. An Bas Dermatol. 2011;

:1193-6.




DOI: http://dx.doi.org/10.29021/spdv.75.4.875

Apontadores

  • Não há apontadores.